Ubs Group Ag Kamada LTD Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$4.78 - $5.75 $91,833 - $110,469
-19,212 Reduced 98.58%
276 $1,000
Q1 2024

May 13, 2024
SELL
$5.58 - $6.42 $312,067 - $359,044
-55,926 Reduced 74.16%
19,488 $109,000
Q4 2023

Feb 09, 2024
BUY
$4.14 - $6.22 $302,534 - $454,532
73,076 Added 3125.58%
75,414 $461,000
Q3 2023

Nov 09, 2023
BUY
$4.86 - $5.83 $11,362 - $13,630
2,338 New
2,338 $12,000
Q1 2023

May 12, 2023
BUY
$4.12 - $5.25 $194,698 - $248,099
47,257 Added 8984.22%
47,783 $221,000
Q4 2022

Feb 08, 2023
SELL
$3.79 - $4.84 $9,183 - $11,727
-2,423 Reduced 82.16%
526 $2,000
Q3 2022

Nov 10, 2022
BUY
$4.42 - $5.43 $2,249 - $2,763
509 Added 20.86%
2,949 $13,000
Q2 2022

Aug 10, 2022
BUY
$4.22 - $5.85 $7,958 - $11,033
1,886 Added 340.43%
2,440 $11,000
Q1 2022

May 16, 2022
SELL
$5.43 - $6.81 $14,807 - $18,570
-2,727 Reduced 83.11%
554 $3,000
Q4 2021

Feb 14, 2022
BUY
$5.21 - $6.82 $17,094 - $22,376
3,281 New
3,281 $22,000
Q3 2021

Nov 15, 2021
SELL
$5.25 - $5.87 $73,893 - $82,620
-14,075 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$5.67 - $6.33 $70,529 - $78,738
12,439 Added 760.33%
14,075 $82,000
Q1 2021

May 12, 2021
SELL
$6.02 - $8.06 $317,374 - $424,923
-52,720 Reduced 96.99%
1,636 $10,000
Q4 2020

Feb 11, 2021
SELL
$6.3 - $8.46 $249,303 - $334,779
-39,572 Reduced 42.13%
54,356 $352,000
Q3 2020

Nov 12, 2020
BUY
$8.02 - $11.73 $34,750 - $50,826
4,333 Added 4.84%
93,928 $785,000
Q2 2020

Jul 31, 2020
BUY
$5.37 - $9.45 $80,383 - $141,457
14,969 Added 20.06%
89,595 $695,000
Q1 2020

May 01, 2020
BUY
$4.56 - $7.13 $36,958 - $57,788
8,105 Added 12.18%
74,626 $435,000
Q4 2019

Feb 14, 2020
BUY
$4.97 - $7.7 $320,405 - $496,403
64,468 Added 3140.19%
66,521 $454,000
Q3 2019

Nov 14, 2019
BUY
$5.11 - $5.99 $10,490 - $12,297
2,053 New
2,053 $11,000
Q1 2019

May 14, 2019
SELL
$5.12 - $6.18 $17,387 - $20,987
-3,396 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$4.68 - $6.25 $987 - $1,318
211 Added 6.62%
3,396 $17,000
Q3 2018

Nov 14, 2018
BUY
$5.15 - $6.3 $1,972 - $2,412
383 Added 13.67%
3,185 $20,000
Q2 2018

Aug 14, 2018
SELL
$4.4 - $5.3 $787 - $948
-179 Reduced 6.0%
2,802 $15,000
Q1 2018

May 15, 2018
BUY
$4.6 - $5.75 $12,332 - $15,415
2,681 Added 893.67%
2,981 $14,000
Q4 2017

Feb 14, 2018
BUY
$4.35 - $5.15 $1,305 - $1,545
300 New
300 $1,000
Q3 2017

Nov 14, 2017
SELL
$4.25 - $4.8 $2,805 - $3,168
-660 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
561 Added 566.67%
660 $4,000
Q1 2017

Nov 14, 2017
BUY
N/A
99
99 $1,000

Others Institutions Holding KMDA

# of Institutions
33
Shares Held
6.48M
Call Options Held
200
Put Options Held
0
View Full List

About KAMADA LTD

KMDA Quotes by TradingView
  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $264M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email